| Virginia Vision Associates | |
|
3800 Fairfax Dr Ste 1, Arlington, VA 22203-1703 | |
| (703) 522-3454 | |
| (703) 522-9636 |
| Full Name | Virginia Vision Associates |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3800 Fairfax Dr Ste 1, Arlington, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295826220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0618000084 (Virginia) | Primary |
| Provider Name | Kathryn E Whitescarver |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1740258987 PECOS PAC ID: 9335139310 Enrollment ID: I20040512001569 |
News Archive
Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.
The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.
› Verified 6 days ago
| Provider Name | Larry Nelson London |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1700818473 PECOS PAC ID: 2769489897 Enrollment ID: I20120221000346 |
News Archive
Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.
The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.
› Verified 6 days ago
| Provider Name | Elizabeth Ann Lobaugh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053419895 PECOS PAC ID: 6901065846 Enrollment ID: I20120312000752 |
News Archive
Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.
The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.
› Verified 6 days ago
| Provider Name | Eric Marcus Kraff |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1679009443 PECOS PAC ID: 2365718400 Enrollment ID: I20171018000427 |
News Archive
Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.
The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Vision Associates 3800 Fairfax Dr Ste 1, Arlington, VA 22203-1703 Ph: (703) 522-3454 | Virginia Vision Associates 3800 Fairfax Dr Ste 1, Arlington, VA 22203-1703 Ph: (703) 522-3454 |
News Archive
Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.
The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.
› Verified 6 days ago
Elizabeth Ann Lobaugh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3800 N Fairfax Drive, Suite 1, Arlington, VA 22203 Phone: 703-522-3454 Fax: 703-522-9636 | |
Dr. Stephan Eugene Hanowsky, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1100 S Hayes St, Arlington, VA 22202 Phone: 703-415-5544 | |
Jeff C. Chuh, O.d. Optometrist Medicare: Medicare Enrolled Practice Location: 1654 Crystal Square Arc, Arlington, VA 22202 Phone: 703-413-9001 Fax: 703-552-1334 | |
My Eye Dr. Optometrist Medicare: Medicare Enrolled Practice Location: 4121 Wilson Blvd Ste 100, Arlington, VA 22203 Phone: 703-525-7474 Fax: 703-525-4108 | |
Dr. Daniel O Olanrewaju, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1100 S Hayes St, Suite 3042, Arlington, VA 22202 Phone: 571-483-0033 Fax: 703-416-9591 | |
Dr. Ume K Chowhan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2823 Clarendon Blvd, Arlington, VA 22201 Phone: 703-294-6600 | |
Dr. Robert William Stetekluh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4238 Wilson Blvd, Suite 3140, Arlington, VA 22203 Phone: 703-524-2800 Fax: 703-524-9493 |